
HCA Healthcare, Inc.: updates and filings
Price
$460.33
November 19, 2026Market cap $96.2B
What Ploutos Investor adds for HCA Healthcare
Part of Ploutos Investor, €9.99 a month
- The full history: 10 fiscal years, from 2016
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Oct 27, 2026next Jan 25, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
October 2026
July 2026
- 29WedDebt and sharesNew material financial obligation, other material eventsDocument
- 28TueReportQuarterly report · for the period to Jun 30, 2026Document
- 24FriResultsResults of operations, Regulation FD disclosure, other material eventsDocument
- 14TueResultsResults of operations, Regulation FD disclosureDocument
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 6, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Nov 5, 2026Material agreement entered, new material financial obligation, other material eventsForm8-K
- Nov 2, 2026Other material eventsForm8-K
- Oct 29, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Oct 27, 2026Results of operations, Regulation FD disclosure, other material eventsForm8-K
- Jul 29, 2026New material financial obligation, other material eventsForm8-K
- Jul 28, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Jul 24, 2026Results of operations, Regulation FD disclosure, other material eventsForm8-K
- Jul 14, 2026Results of operations, Regulation FD disclosureForm8-K
- Jun 18, 2026Officer or director changeForm8-K
- Apr 30, 2026Material agreement entered, new material financial obligation, other material eventsForm8-K
- Apr 30, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Apr 29, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- Apr 28, 2026Shareholder voteForm8-K
- Apr 27, 2026Other material eventsForm8-K
- Apr 27, 2026Shelf registration for future offeringsFormS-3ASR
- Apr 24, 2026Results of operations, Regulation FD disclosure, other material eventsForm8-K
- Mar 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Mar 13, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Mar 13, 2026Additional annual meeting materialFormDEFA14A
- Mar 13, 2026Annual meeting proxy statementFormDEF 14A
- Feb 25, 2026Officer or director changeForm8-K
- Feb 10, 2026Over-5% holder statement (active)FormSCHEDULE 13D
- Feb 10, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Jan 27, 2026Results of operations, Regulation FD disclosure, other material eventsForm8-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 6, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Nov 5, 2026 | 8-K | Material agreement entered, new material financial obligation, other material events | Document |
| Nov 2, 2026 | 8-K | Other material events | Document |
| Oct 29, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Oct 27, 2026 | 8-K | Results of operations, Regulation FD disclosure, other material events | Document |
| Jul 29, 2026 | 8-K | New material financial obligation, other material events | Document |
| Jul 28, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Jul 24, 2026 | 8-K | Results of operations, Regulation FD disclosure, other material events | Document |
| Jul 14, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Jun 18, 2026 | 8-K | Officer or director change | Document |
| Apr 30, 2026 | 8-K | Material agreement entered, new material financial obligation, other material events | Document |
| Apr 30, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Apr 29, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| Apr 28, 2026 | 8-K | Shareholder vote | Document |
| Apr 27, 2026 | 8-K | Other material events | Document |
| Apr 27, 2026 | S-3ASR | Shelf registration for future offerings | Document |
| Apr 24, 2026 | 8-K | Results of operations, Regulation FD disclosure, other material events | Document |
| Mar 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Mar 13, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Mar 13, 2026 | DEFA14A | Additional annual meeting material | Document |
| Mar 13, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Feb 25, 2026 | 8-K | Officer or director change | Document |
| Feb 10, 2026 | SCHEDULE 13D | Over-5% holder statement (active) | Document |
| Feb 10, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Jan 27, 2026 | 8-K | Results of operations, Regulation FD disclosure, other material events | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Feb 10, 1994. Of its note and share prospectuses (424B, FWP), the newest 40 of 160.
The full analysis
What do HCA Healthcare's filings show?
The filings are where every one of HCA Healthcare's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.